Astatine-211 targeted alpha therapy

· Osaka University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Astatine-211 targeted alpha therapy, covering 2025-04-24 to 2025-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Targeted Alpha Therapy Using Astatine (At-211) Against Differentiated Thyroid Cancer [Phase 1]